@ARTICLE{
author={Zimran Ari,Gonzalez-Rodriguez Derlis Emilio,Abrahamov Aya,Cooper Peter A,Varughese Sheeba,Giraldo Pilar,Petakov Milan S,Tan Ee Shien,Chertkoff Raul},
year={2018},
title={Long-term safety and efficacy of taliglucerase alfa in pediatric Gaucher disease patients who were treatment-naive or previously treated with imiglucerase},
journal={BLOOD CELLS MOLECULES AND DISEASES},
volume={68},
number={},
pages={163-172},
document_type={Article},
} 

@ARTICLE{
author={Pastores Gregory M,Petakov Milan S,Giraldo Pilar,Rosenbaum Hanna,Szer Jeffrey,Deegan Patrick B,Amato Dominick J,Mengel Eugen,Tan Ee Shien,Chertkoff Raul,Brill-Almon Einat,Zimran Ari},
year={2014},
title={A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase},
journal={BLOOD CELLS MOLECULES AND DISEASES},
volume={53},
number={4},
pages={253-260},
document_type={Article},
}